Contents
Contents
Wound physician billing fraud involves knowingly charging Medicare for wound treatment that was unnecessary, never performed or more extensive than the care delivered. A routine cleaning becomes surgery, the software supplies a tissue measurement the physician never entered, or a procedure produces an extra office-visit charge. If you treat the patient, code the encounter or maintain the system, you may know where the clinical account became a billing story.
The cases against Vohra Wound Physicians Management and Healogics show how this form of physician billing fraud can reach beyond the billing desk. These health care fraud allegations connect treatment targets, software design, training and management’s response to concerns. Those connections explain why the same kind of claim can keep appearing across physicians and facilities.
Wound care delivered in a nursing home can produce a claim for the physician’s professional work. Vohra provides bedside specialty wound care in nursing homes and skilled nursing facilities. In November 2025, Vohra and its owner agreed to pay $45 million to resolve allegations involving unnecessary surgical procedures, routine care billed as surgery and evaluation and management services that Medicare did not separately cover.
The care setting helps explain the alleged incentive. The government’s complaint describes surgical excisional debridement as separately reimbursable under Medicare Part B, including in skilled nursing facilities. Selective debridement can already be included in the facility’s bundled payment. Calling the bedside procedure surgery could therefore change both the amount billed and whether a separate claim reached Medicare at all.
For the physician or facility liaison, the important comparison is the treatment delivered against the service the wound-care company billed. The facility’s records may describe the wound before and after the physician’s visit. In Vohra’s case, photographs taken by people outside the company became part of the government’s account of why particular surgical claims did not match the wound.
Surgical debridement billing turns on the tissue actually removed, including its depth and area. The Vohra complaint distinguishes cutting out unhealthy tissue to expose healthy bleeding tissue from more superficial maintenance of the wound bed, though both can involve a sharp instrument.
The government alleged that Vohra removed the choice between selective and surgical excisional debridement from its electronic medical record in 2015. For the next eight years, physicians saw a general debridement option while the system automatically billed the surgical procedure. The choice disappeared from the screen. The higher-paying claim remained.
The alleged software design also converted the amount of unhealthy tissue present into the amount removed. Physicians could record how much necrotic or devitalized tissue was in the wound, but the system assumed that all of it had been debrided. It inserted that measurement into the medical record and selected the billing codes, including additional charges for larger areas. The government’s complaint put the problem plainly:
Vohra WPM’s EMR essentially invented a number, put it in the medical record, and billed Medicare extra based on it.
That allegation reaches past the final code to the supposed evidence behind it. A reviewer opening the generated note would see a tissue-removal measurement that, according to the complaint, the treating physician had never supplied. We see a system allegedly writing the evidence for its own bill.
Healogics’ whistleblowers described a parallel problem in their Florida complaint. They alleged that the company trained physicians to bill minor selective debridements as surgical procedures and treated a wound’s depth as a reason to code the debridement automatically as surgical. Their account points to the same comparison: the wound’s condition before treatment, the tissue actually removed and the procedure represented on the claim.
Modifier 25 fraud adds an evaluation and management payment for work already included in a procedure. The Vohra complaint explains that surgical excisional debridement includes an examination, while an additional E/M claim requires significant, separately identifiable work. A notation about another wound became the alleged shortcut around that requirement.
According to the government, Vohra’s system prompted the physician to note the status of wounds that were not debrided. That notation automatically generated an E/M claim with Modifier 25, regardless of the work performed. The second wound supplied the billing trigger even when it had required no separate clinical work.
Healogics’ separate Iowa settlement concerned the same added-visit representation. The company agreed to pay $398,162 in June 2018 to resolve allegations that it used the modifier when no separate service had been performed. Those claims involved Medicare, Medicaid and TRICARE.
The Iowa whistleblower’s complaint alleged that an antibiotic prescription written during debridement triggered an additional physician E/M charge. It also described dressing and wrapping visits billed at levels unsupported by the clinical work documented in the chart, which showed only nursing care. The whistleblower traced the coding to a centrally created corporate manual.
The complaint further alleged that a compliance team decided to stop using one higher visit code for nurse-only encounters but continue another. The compliance officers justified the remaining code as covering facility and equipment costs. In that account, a physician visit became a way to bill for the building’s overhead.
Repeated debridement claims can reveal the business instruction behind a treatment pattern. In the Healogics Florida complaint, the whistleblowers alleged a benchmark requiring debridement of 60% of all wounds assessed, with 80% of those procedures at the higher-paying surgical level. The target reached both how often physicians treated a wound and how they classified the work.
Vohra’s alleged pressure operated through its software and physician management. The government said that recording devitalized material made debridement mandatory in the system unless the physician selected a narrow exception. Management monitored those exceptions and retrained physicians who used them too often. The complaint also described mentoring, revenue targets and decisions about which facilities physicians would be assigned.
One chart review described in the complaint found no clear evidence that a physician was debriding too little, yet still suggested she should be more aggressive because of her performance index. That is the revealing comparison: the charts supplied no clear clinical shortfall, but the metric supplied a reason to demand more. For an insider, the review comments and the target reports explain a part of the claim that the procedure note alone cannot.
The government’s patient examples tied those pressures to repeated billing. It alleged that Vohra submitted twenty-eight surgical debridement claims after a wound’s treatment goal had changed from healing to palliation. In another example, an outside photograph allegedly showed intact skin after a billed muscle-level surgical debridement. These medical necessity and unsupported-treatment allegations turn on the patient’s actual condition and care plan, alongside the demand for another procedure.
Hyperbaric oxygen therapy uses oxygen at increased atmospheric pressure, and Healogics’ Florida settlement addressed allegations that wound centers billed Medicare for unnecessary or unreasonable treatments. In its June 2018 announcement, the Justice Department described a company managing nearly 700 hospital-based wound-care centers. The settlement included a $17.5 million fixed payment.
The Florida whistleblowers’ complaint shows how pressure allegedly reached the treatment decision. A program director said a manager refused another nurse until hyperbaric treatment volume increased. Yet the staffing measure for wound-care visits excluded activity in the hyperbaric suite. According to that account, a center’s need for nursing help became a reason to push a separate billable treatment.
The same complaint alleged falsified eligibility for hyperbaric treatment and unnecessary transcutaneous oxygen measurement, commonly called TCOM. It described a directive for universal testing that allegedly generated tens of thousands of unnecessary claims. The complaint’s treatment and testing allegations show why the clinical reason for the order matters alongside the utilization report.
An insider may recognize the pressure in a staffing request, a discussion of treatment eligibility or a directive to test every patient. Those exchanges can explain why the clinician ordered the service that Medicare later paid for.
We build a wound-care whistleblower’s case by connecting the patient’s condition, the work actually performed and the claim submitted for payment. Wound photographs and treatment notes show the clinical history. The schedule and signatures identify the people involved, while software settings, coding manuals and management instructions can explain why the billed service differed from the care delivered.
The 2017 Journal of AHIMA article Busting Bad Medicine: a Call to Action Addressing Healthcare, Fraud, Waste, and Abuse describes comparing treatment dates, treatment types and nurse or physician signatures. Its point about the people behind those records is particularly useful when a system generates its own clinical language:
Fraud examiners and investigators will not just stop at documentation alone. They will ask for trustworthy witnesses who can tell them what they know about the fraud.
The audit response adds another part of the story. The Vohra complaint alleged that an outside expert found a 30.85% error rate for incorrectly billed E/M services using Modifier 25. Senior management allegedly received the results without returning overpayments or immediately correcting the system. Someone who knows what changed after an audit, or who decided to leave the programming in place, can connect the warning to later claims.
The civil resolution also reached the technology. The Vohra settlement announcement required independent review of claims and health information technology systems under its corporate integrity agreement. That requirement fits the alleged mechanism: examining the claim alone would leave the system that produced it out of view.
Skin substitutes bring product selection and purchasing into wound-care billing. In its September 2025 review, the HHS Office of Inspector General reported that annual Medicare Part B expenditures had surpassed $10 billion by the end of 2024. Among patients with a skin-substitute claim, costs for those reportedly treated at home were four times those in an office setting.
The inspector general identified rising utilization, higher prices and spread-pricing incentives that could make certain products more attractive to providers. CMS’s 2026 physician payment rule moved skin-substitute products to payment as supplies used with a covered application procedure in physician offices and hospital outpatient departments.
The Justice Department’s national takedown case summaries describe a criminal indictment against the owner of Protectus LLC alleging that skin-substitute kickbacks were disguised as rebates or discounts. A separate indictment described there charged a nurse practitioner who owned mobile wound clinics with causing unnecessary allograft applications, including on infected or already healed wounds, and falsifying records to justify them.
The practical connection runs from who chose the product to why it was applied and what the government was billed. In the mobile-clinic indictment, prosecutors alleged that conservative wound care had not been attempted, completed or confirmed before the allografts were applied. A clinician’s account of the earlier care can explain what the product claim leaves out.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. A physician-practice qui tam case brings the insider’s account of how the claim was made into that process. We shape your case around the people who set the treatment targets and the billing instructions, and stay with you through the decisions ahead.
If you have seen a treatment target override the wound assessment or a system create work the clinician never recorded, talk with our wound-care billing whistleblower experts. We develop the case with you and bring in healthcare fraud whistleblower lawyers who understand professional billing, medical necessity and the software behind the claim. We stay beside you through the decisions that turn your knowledge of the care into a case about the government’s money.